Angioedema Newswire

Angioedema Newswire

Comprehensive Real-Time News Feed for Angioedema.

Results 1 - 8 of 8 in Angioedema

  1. Patient Advocates and Big Pharma Fund Nation's First Angioedema Treatment CenterRead the original story

    Feb 8, 2015 | San Diego NewsCape

    ... pharmaceutical companies to invest in an endowment to fund this type of center. Fortunately, the US Hereditary Angioedema Association (HAEA), a nonprofit patient advocacy organization, along with four pharmaceutical companies Shire Human Genetics ...

    Comment?

  2. Recent Study: CSL Behring LLC - Strategic SWOT Analysis ReviewRead the original story

    Jan 23, 2015 | PR-inside.com

    ... productys find application in the treatment of diseases such as bleeding disorders, fluid replacement, hereditary angioedema, wound healing, hemophilia, primary immunodeficiency (PID), von willebrand disease (VWD), genetic emphysema, fibrinogen ...

    Comment?

  3. BioCryst jumps on angioedema drug newsRead the original story w/Photo

    Jan 14, 2015 | MarketWatch

    ... company said it received a positive opinion on European orphan drug designation for its treatment for hereditary angioedema. The disease is a rare and potentially fatal genetic condition that causes edema, or organ swelling, in various parts of the ...

    Comment?

  4. FDA awards orphan drug designation to BioCryst's HAE treatmentRead the original story w/Photo

    Dec 24, 2014 | Business Journal

    Durham's BioCryst Pharmaceuticals received an orphan drug designation for its angioedema treatment under development, an important measure because it allows BioCryst to accelerate its development timeline. Orphan drug designation is granted by the U.S. Food and Drug Administration to novel drugs intended for the safe and effective treatment of a rare disease or condition that affects fewer than 200,000 patients in the United States.

    Comment?

  5. Angioedema - The Skin Disorder That WeltsRead the original story w/Photo

    Dec 17, 2014 | Natural Holistic Health

    Angioedema is a skin condition that involves swelling in both the tissue and mucous membranes. It occurs in much the same way as hives except not on the skin surface.

    Comment?

  6. First Angioedema Treatment Center Opens at UC San Diego Health SystemRead the original story w/Photo

    Nov 30, 2014 | San Diego NewsCape

    UC San Diego Health System in partnership with the U.S. Hereditary Angioedema Association , a non-profit patient advocacy organization, has opened the nation's first dedicated center for diagnosing and treating diverse forms of swelling, known collectively as angioedema. The U.S. HAEA Angioedema Center at UC San Diego Health System will serve as an international referral center for people with all types of angioedema and will work closely with basic science laboratories at UC San Diego School of Medicine to better understand the condition and develop new treatments.

    Comment?

  7. First Angioedema Treatment Center Opens at UC San Diego Health SystemRead the original story w/Photo

    Nov 24, 2014 | Patch.com

    Angioedema is a swelling that is similar to hives, but the swelling is under the skin instead of on the surface. UC San Diego Health System in partnership with the U.S. Hereditary Angioedema Association , a non-profit patient advocacy organization, has opened the nation's first dedicated center for diagnosing and treating diverse forms of swelling, known collectively as angioedema.

    Comment?

  8. UC San Diego Health System opens nation's first angioedema treatment centerRead the original story w/Photo

    Nov 24, 2014 | Medical News

    UC San Diego Health System in partnership with the U.S. Hereditary Angioedema Association , a non-profit patient advocacy organization, has opened the nation's first dedicated center for diagnosing and treating diverse forms of swelling, known collectively as angioedema. The U.S. HAEA Angioedema Center at UC San Diego Health System will serve as an international referral center for people with all types of angioedema and will work closely with basic science laboratories at UC San Diego School of Medicine to better understand the condition and develop new treatments.

    Comment?